These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38981792)

  • 1. Knowledge Graphs in Pharmacovigilance: A Scoping Review.
    Hauben M; Rafi M; Abdelaziz I; Hassanzadeh O
    Clin Ther; 2024 Jul; 46(7):544-554. PubMed ID: 38981792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review.
    Golder S; O'Connor K; Wang Y; Klein A; Gonzalez Hernandez G
    JMIR Public Health Surveill; 2024 Sep; 10():e59167. PubMed ID: 39240684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge Graphs in Pharmacovigilance: A Step-By-Step Guide.
    Hauben M; Rafi M
    Clin Ther; 2024 Jul; 46(7):538-543. PubMed ID: 38670887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of patient reporting to the pharmacovigilance system: a systematic review.
    Inácio P; Cavaco A; Airaksinen M
    Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy.
    Putri RA; Ikawati Z; Rahmawati F; Yasin NM
    Curr Drug Saf; 2024; 19(3):317-331. PubMed ID: 38989832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating duplication in pharmacovigilance databases: a scoping review.
    Kiguba R; Isabirye G; Mayengo J; Owiny J; Tregunno P; Harrison K; Pirmohamed M; Ndagije HB
    BMJ Open; 2024 Apr; 14(4):e081990. PubMed ID: 38684275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review.
    Shafi J; Virk MK; Kalk E; Carlucci JG; Chepkemoi A; Bernard C; McHenry MS; Were E; Humphrey J; Davies MA; Mehta UC; Patel RC
    Drug Saf; 2024 Oct; 47(10):957-990. PubMed ID: 38907172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
    Stergiopoulos S; Fehrle M; Caubel P; Tan L; Jebson L
    Pharmaceut Med; 2019 Dec; 33(6):499-510. PubMed ID: 31933240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches.
    De Abreu Ferreira R; Zhong S; Moureaud C; Le MT; Rothstein A; Li X; Wang L; Patwardhan M
    Adv Ther; 2024 Jun; 41(6):2435-2445. PubMed ID: 38704799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
    Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
    Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.
    Khan Z; Karatas Y; Hamid SM
    PLoS One; 2023; 18(5):e0285811. PubMed ID: 37224133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
    Edrees H; Song W; Syrowatka A; Simona A; Amato MG; Bates DW
    Drug Saf; 2022 May; 45(5):449-458. PubMed ID: 35579810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.
    Khouri C; Revol B; Lepelley M; Mouffak A; Bernardeau C; Salvo F; Pariente A; Roustit M; Cracowski JL
    J Clin Epidemiol; 2021 Nov; 139():191-198. PubMed ID: 34329725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug-drug interactions.
    Kontsioti E; Maskell S; Pirmohamed M
    Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):832-844. PubMed ID: 36916014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
    Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
    Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions' reporting in a Mexican hospital.
    Valdez-Ramírez LA; Serrano-Medina A; Cornejo-Bravo JM
    Int J Pharm Pract; 2020 Dec; 28(6):660-662. PubMed ID: 32476179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.
    Muñoz MA; Dal Pan GJ; Wei YJ; Delcher C; Xiao H; Kortepeter CM; Winterstein AG
    Drug Saf; 2020 Apr; 43(4):329-338. PubMed ID: 31912439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
    Fusaroli M; Salvo F; Begaud B; AlShammari TM; Bate A; Battini V; Brueckner A; Candore G; Carnovale C; Crisafulli S; Cutroneo PM; Dolladille C; Drici MD; Faillie JL; Goldman A; Hauben M; Herdeiro MT; Mahaux O; Manlik K; Montastruc F; Noguchi Y; Norén GN; Noseda R; Onakpoya IJ; Pariente A; Poluzzi E; Salem M; Sartori D; Trinh NTH; Tuccori M; van Hunsel F; van Puijenbroek E; Raschi E; Khouri C
    Drug Saf; 2024 Jun; 47(6):575-584. PubMed ID: 38713346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
    Yang CC; Yang H
    Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.